Colored light micrograph of brain tissue from an Alzheimer’s disease sufferer. Both of the classic pathological features of this disease are seen here. At lower right is a large plaque (pink/blue) containing the abnormal protein amyloid. Also seen are several neurofibrillary tangles (smaller blue areas), thickened parts of the cytoplasm of nerve cells. Both of these abnormalities disrupt the normal working of the brain. The symptoms of Alzheimer’s Disease include memory loss (particularly of recent events), disorientation and mood changes. Death occurs after several years of decline, and there is no cure. Magnification: x50 at 6x7cm size.
(Image/Simon Fraser, Science Source)
The power of simulations combined with experiments reveals why protein agglomerations typical of neurodegenerative diseases dissociate with infrared laser irradiation
The agglomeration of proteins into structures called amyloid plaques is a common feature of many neurodegenerative diseases, including Alzheimer’s. Now, scientists reveal, through experiments and simulations, how resonance with an infrared laser, when it is tuned to a specific frequency, causes amyloid fibrils to disintegrate from the inside out. Their findings open doors to novel therapeutic possibilities for amyloid plaque-related neurodegenerative diseases that have thus far been incurable.
A notable characteristic of several neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, is the formation of harmful plaques that contain aggregates-also known as fibrils-of amyloid proteins. Unfortunately, even after decades of research, getting rid of these plaques has remained a herculean challenge. Thus, the treatment options available to patients with these disorders are limited and not very effective.
In recent years, instead of going down the chemical route using drugs, some scientists have turned to alternative approaches, such as ultrasound, to destroy amyloid fibrils and halt the progression of Alzheimer’s disease. Now, a research team led by Dr Takayasu Kawasaki (IR-FEL Research Center, Tokyo University of Science, Japan) and Dr Phuong H. Nguyen (Centre National de la Recherche Scientifique, France), including other researchers from the Aichi Synchrotron Radiation Center and the Synchrotron Radiation Research Center, Nagoya University, Japan, has used novel methods to show how infrared-laser irradiation can destroy amyloid fibrils.
In their study,published in Journal of Physical Chemistry B, the scientists present the results of laser experiments and molecular dynamics simulations. This two-pronged attack on the problem was necessary because of the inherent limitations of each approach, as Dr Kawasaki explains, “While laser experiments coupled with various microscopy methods can provide information about the morphology and structural evolution of amyloid fibrils after laser irradiation, these experiments have limited spatial and temporal resolutions, thus preventing a full understanding of the underlying molecular mechanisms. On the other hand, though this information can be obtained from molecular simulations, the laser intensity and irradiation time used in simulations are very different from those used in actual experiments. It is therefore important to determine whether the process of laser-induced fibril dissociation obtained through experiments and simulations is similar.”
The scientists used a portion of a yeast protein that is known to form amyloid fibrils on its own. In their laser experiments, they tuned the frequency of an infrared laser beam to that of the “amide I band” of the fibril, creating resonance. Scanning electron microscopy images confirmed that the amyloid fibrils disassembled upon laser irradiation at the resonance frequency, and a combination of spectroscopy techniques revealed details about the final structure after fibril dissociation.
For the simulations, the researchers employed a technique that a few members of the current team had previously developed, called “nonequilibrium molecular dynamics (NEMD) simulations.” Its results corroborated those of the experiment and additionally clarified the entire amyloid dissociation process down to very specific details. Through the simulations, the scientists observed that the process begins at the core of the fibril where the resonance breaks intermolecular hydrogen bonds and thus separates the proteins in the aggregate. The disruption to this structure then spreads outward to the extremities of the fibril.
Together, the experiment and simulation make a good case for a novel treatment possibility for neurodegenerative disorders. Dr Kawasaki remarks, “In view of the inability of existing drugs to slow or reverse the cognitive impairment in Alzheimer’s disease, developing non-pharmaceutical approaches is very desirable. The ability to use infrared lasers to dissociate amyloid fibrils opens up a promising approach.”
The team’s long-term goal is to establish a framework combining laser experiments with NEMD simulations to study the process of fibril dissociation in even more detail, and new works are already underway. All these efforts will hopefully light a beacon of hope for those dealing with Alzheimer’s or other neurodegenerative diseases.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Cleveland Clinic research identifies sildenafil as candidate drug for Alzheimer’s disease
A new Cleveland Clinic-led study has identified sildenafil – an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Ravatio) – as a promising drug candidate to help ...
- Study identifies sildenafil as candidate drug for Alzheimer's disease
A new Cleveland Clinic-led study has identified sildenafil—an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Ravatio)—as a promising drug candidate to help prevent ...
- Microglia Play a Role in the Relationship between the Gut Microbiome and β-Amyloid Deposits
Researchers from the University of Chicago have discovered that microglia play a key role in the relationship between the gut microbiome and β-amyloid deposits in male mice in a model of Alzheimer’s ...
- Brain Aging May Be Faster for People With Childhood-Onset Epilepsy
Childhood-onset epilepsy appeared to accelerate brain aging by about 10 years, a small prospective study in Finland suggested. Over about 55 years of follow-up, people with childhood-onset epilepsy ...
- As Medicare Decides Whether To Pay For Aduhelm To Treat Alzheimer’s Disease, Its Future Is Uncertain
CMS has embarked on a national coverage determination process, in which it's examining the clinical safety and benefit profile of Aduhelm and other anti beta amyloid monoclonal antibodies in Alzheimer ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- New treatment for chronic migraines shows promise
A new non-medicinal treatment gives hope for curing chronic migraines, Kaohsiung Veterans General Hospital announced after clinical trials on 15 patients showed positive results. In one case, a woman ...
- Ultrashort-pulse lasers tackle drug-resistant bacteria
A project at Washington University School of Medicine in St. Louis has now demonstrated a possible advance in the fight against MDROs, and shown how ultrashort laser pulses can kill drug-resistant ...
- Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury
[The effect of continuous low-intensity laser irradiation of the red spectrum on the changes in the functional activity and speed of NADPH-oxidase response of human peripheral blood neutrophils].
- Blood Irradiation Market Research Report by Offering, by Deployment Type, by Organization Size, by Vertical, by Region – Global Forecast to 2026
This method is employed for the ultraviolet (UV) blood irradiation (UVBI) by UV lamps. The laser light is monochromatic, i.e. it’s such a wavelength that permits you to bring light into the ...
- Halberd Successfully Eradicates TNF-alpha, Major Contributing Factor to Alzheimer's Disease
TNF-α was eliminated through exposure to tuned laser irradiation. TNF-α is an inflammatory cytokine which has been identified as a major contributor to Alzheimer's Disease, and recently has been ...